The ability of revolutionary therapies to treat a number of disorders, ranging from AMD to congenital degenerations, is being studied. A lot of firms are looking into using regenerative medicine to treat eye disorders. Stem cell delivery technologies have vastly improved, paving the possibility for more stem cell use. To replace or enhance the body's natural healing process, regenerative medicine uses diverse combinations of specially generated cells, tissues, and laboratory-made chemicals. Regenerative Medicine is expected to have an impact on the health-care business equivalent to that of antibiotics, vaccines, and, more recently, monoclonal antibodies in clinical care. Regenerative medicine is steadily progressing, but there are still many obstacles to overcome.
• Cell Therapy
• Transplantation
• Stem Cell
• Types
• Approaches and Challenges
Market Analysis:
The global regenerative medicine market reached a value of US$ 14.78 Billion in 2021 and expecting to reach US$ 50.44 Billion by 2027, exhibiting a CAGR of 22.6% during 2022-2027.
ALSO READ Biochemistry and Molecular Biology Cataract Clinical and Epidemiologic Research Clinical Ophthalmology Cornea Diabetic Retinopathy External Eye Disease Eye Anatomy Eye Infections and Allergies Glaucoma Immunology and Microbiology Lens Disorder Nano Ophthalmology Neuro Ophthalmology Ocular Inflammation Ocular Oncology Ophthalmic Pathology Ophthalmology Surgery Optometry Pediatric Ophthalmology Pharmacology Regenerative Medicine Retina Retinal Cell Biology Retinal Imaging Spatial Vision Translational Research Uveitis Scleritis Vision Therapy Vitreous Disorders
Tags
European Ophthalmology Conferences
Eye Conferences
Optometry Conferences
Cornea Conferences
Ophthalmology Conferences
Ophthalmologists Conferences 2023
Pediatric Ophthalmology Conferences
Cataract Conferences